Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 5
2016 8
2017 9
2018 12
2019 17
2020 18
2021 17
2022 19
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Reviews in genitourinary oncology.
Arcangeli S, Lancia A, Ingrosso G, Triggiani L, Wilkins A. Arcangeli S, et al. Among authors: triggiani l. Front Oncol. 2023 Apr 13;13:1196769. doi: 10.3389/fonc.2023.1196769. eCollection 2023. Front Oncol. 2023. PMID: 37124515 Free PMC article. No abstract available.
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).
Francolini G, Allegra AG, Detti B, Di Cataldo V, Caini S, Bruni A, Ingrosso G, D'Angelillo RM, Alitto AR, Augugliaro M, Triggiani L, Parisi S, Facchini G, Banini M, Simontacchi G, Desideri I, Meattini I, Valicenti RK, Livi L; ARTO Working Group members. Francolini G, et al. Among authors: triggiani l. J Clin Oncol. 2023 Dec 20;41(36):5561-5568. doi: 10.1200/JCO.23.00985. Epub 2023 Sep 21. J Clin Oncol. 2023. PMID: 37733977 Clinical Trial.
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study.
Archer P, Marvaso G, Detti B, Colombo F, Francolini G, Vandendorpe B, Thananayagam MA, Baty M, De Crevoisier R, Alongi F, Nicosia L, Scher N, Toledano A, Di Muzio N, Fodor A, Zilli T, Franzese C, Scorsetti M, Shelan M, Triggiani L, Aymes E, Le Deley MC, Jereczek-Fossa BA, Pasquier D. Archer P, et al. Among authors: triggiani l. Eur Urol Oncol. 2023 Jun;6(3):303-310. doi: 10.1016/j.euo.2023.03.005. Epub 2023 Apr 1. Eur Urol Oncol. 2023. PMID: 37012102
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis.
Francolini G, Garlatti P, Di Cataldo V, Triggiani L, Simoni N, Detti B, Lorenzetti V, Colombo F, Morelli V, Ganovelli M, Caprara L, Orsatti C, Burchini L, Frosini G, Bertini N, Loi M, Simontacchi G, Greto D, Desideri I, Meattini I, Livi L. Francolini G, et al. Among authors: triggiani l. Radiol Med. 2023 Nov;128(11):1423-1428. doi: 10.1007/s11547-023-01701-x. Epub 2023 Aug 19. Radiol Med. 2023. PMID: 37597125
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma.
Buglione M, Guerini AE, Filippi AR, Spiazzi L, Pasinetti N, Magli A, Toraci C, Borghetti P, Triggiani L, Alghisi A, Costantino G, Bertagna F, Giaj Levra N, Pegurri L, Magrini SM. Buglione M, et al. Among authors: triggiani l. Crit Rev Oncol Hematol. 2021 Nov;167:103437. doi: 10.1016/j.critrevonc.2021.103437. Epub 2021 Aug 3. Crit Rev Oncol Hematol. 2021. PMID: 34358649 Review.
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease.
Alongi F, Arcangeli S, Triggiani L, Mazzola R, Buglione di Monale E Bastia M, Fersino S, Baiguini A, Jereczek-Fossa BA, Magrini SM; on the behalf of Italian Association of Radiation Oncology [AIRO]. Alongi F, et al. Among authors: triggiani l. Crit Rev Oncol Hematol. 2017 Sep;117:48-56. doi: 10.1016/j.critrevonc.2017.07.004. Epub 2017 Jul 13. Crit Rev Oncol Hematol. 2017. PMID: 28807235 Review.
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors.
Codenotti S, Zizioli D, Mignani L, Rezzola S, Tabellini G, Parolini S, Giacomini A, Asperti M, Poli M, Mandracchia D, Vezzoli M, Bernardi S, Russo D, Mitola S, Monti E, Triggiani L, Tomasini D, Gastaldello S, Cassandri M, Rota R, Marampon F, Fanzani A. Codenotti S, et al. Among authors: triggiani l. Cells. 2022 Sep 14;11(18):2859. doi: 10.3390/cells11182859. Cells. 2022. PMID: 36139434 Free PMC article.
97 results